Chlamydia Diagnosis And Treatment Market Size, Share and Forecast to 2025

Chlamydia diagnosis and treatment market are expected to grow noticeably across the globe. Chlamydia is a very common sexually transmitted disease across the globe which is caused by the bacteria known as chlamydia trachomatis. If chlamydia is left untreated for long duration it can lead to a pelvic inflammatory disease which in turn will show additional symptoms such as ectopic pregnancy, infertility, and chronic pelvic pain. According to WHO the sexually transmitted infections are increasing across the globe in recent. Chlamydia trachomatis and Neisseria gonorrhoeae are the most frequent bacteria of sexually transmitted infections and each cause approximately 106 million new infections every year. It is likely that the new infection number would be even higher as many infections are asymptomatic and remain undiagnosed.

Request a free sample of our report on Chlamydia Diagnosis And Treatment Market: https://www.omrglobal.com/request-sample/chlamydia-disease-diagnosis-treatment-market

Having sexually transmitted infections such as chlamydia alone increases the risk of getting HIV as most of the sexually transmitted infections causes sores or lesions making it easier for HIV infection to enter into the body. So, it is mandatory to treat the chlamydia starting from the proper diagnosis. There are many lab tests available for the diagnosis of chlamydia which requires the sample that may be taken from the cervix or vagina in case of women and taken from the urethra in case of men. In the case of oral sex, the sample is collected from rectum or throat.

A full report of Global Chlamydia Diagnosis And Treatment Market is available at: https://www.omrglobal.com/industry-reports/chlamydia-disease-diagnosis-treatment-market

In many countries, self-testing kits for chlamydia are also available supporting people to test themselves without intervention from any healthcare professional which is driving the chlamydia diagnosis and treatment market. These self-testing kits reduce the hassle of uncertainty among patients and in this way the access to the correct diagnosis will increase as more people will use it. Chlamydia is associated with a high level of stigma and providing self-testing kits will increase the diagnosis rate among people since most people otherwise hesitate to come forward for testing.

A company named EverlyWell, Inc. provides a test for chlamydia in which the testing kit is ordered by the patient in their home and the barcode associated with the kit is entered into the company’s website and the test sample taken at home is sent back to the company. The physicians associated with the company analyze the sample and the final result is displayed on the company’s secure platform. Using this way, the privacy of the patient is preserved, and the correct diagnosis of chlamydial can be obtained.

A key concern about the self-testing kit and diagnosis lies in its accuracy and errors in sample handling that could hamper the final diagnosis. Also, the absence of professional support can also be considered as a disadvantage as most people feel more confident when the diagnosis is done under the observation of physicians. The advancement in the testing devices like nucleic acid amplification test coupled with the increased number of individuals undergoing screening is directly implying that the number of reported chlamydia trachomatis infection is also rising.

Global Chlamydia Diagnosis and Treatment Market- Segmentation

By Diagnosis Methods

Chlamydia Culture
Urine Culture
Enzyme Immunoassays
Nucleic Acid Amplification Test

By Treatment Approach

Oral Antibiotics
Azithromycin
Doxycycline
Other

By End-User

Hospitals
Diagnostic Centers
Research Institutions

Global Chlamydia Diagnosis and Treatment Market- Segment by Region

North America

US
Cana

Europe

Germany
UK
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Company Name: Orion Market Reports

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +1 646-755-7667, +91 780-304-0404

Orion Market Research (OMR) is an Indian market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.